Stock to buy today: Citi sees 17% upside in Paytm; Jefferies maintain buy on Dalmia BharatBrokerage firms remain optimistic about Dalmia Bharat, KEI Industries, and Paytm despite sectoral challenges. Jefferies targets 17% upside ...
22 Jan, 2025, 09.39 AM IST
Stock to buy today: Citi sees 17% upside in Paytm; Jefferies maintain buy on Dalmia BharatBrokerage firms remain optimistic about Dalmia Bharat, KEI Industries, and Paytm despite sectoral challenges. Jefferies targets 17% upside ...
22 Jan, 2025, 09.36 AM IST
Philippine fintech GCash hires banks for up to $1.5 billion IPO, sources sayThe IPO is expected to take place as early as the second half of 2025 or in 2026, subject to broader market conditions, two of the sources ...
10 Jan, 2025, 03.59 PM IST
Hot stocks: Brokerage views on Varun Beverages, PB Fintech, Tata Tech, 360 One and GMR AirportsBrokerage firms have issued varied ratings on several stocks: HSBC and Jefferies maintain buy ratings on Varun Beverages and GMR Airports, ...
10 Oct, 2024, 09.02 AM IST
Hot stocks: Brokerage view on Tata Tech, Zomato and Shriram FinanceCiti has issued a sell rating on Tata Tech with a target price of Rs 945, citing uncertainties related to VinFast revenues and client conce...
09 Sep, 2024, 09.15 AM IST
Hot stocks: Brokerage view on Paytm, Vodafone Idea and Jana Small Finance BankBrokerage firms UBS, Jefferies, Citi, and Investec have offered varied ratings on Indian stocks. UBS and Jefferies give Paytm neutral and h...
29 Aug, 2024, 09.01 AM IST
Hot stocks: Brokerage view on Shyam Metalics, IndiGo, Vedanta, Zomato and PaytmBrokerage firms have issued diverse stock recommendations: UBS endorsed Shyam Metalics as a buy, Jefferies upgraded IndiGo and Zomato to bu...
22 Aug, 2024, 09.35 AM IST
Hot stocks: Brokerage view on Ramco Cements, Tech Mahindra, Laurus Labs, Syngene and CyientCiti has maintained a sell call on Ramco Cements, raising the target price to Rs 750 from Rs 735. Despite stable EBITDA per ton, Ramco has ...
26 Jul, 2024, 09.28 AM IST
Hot stocks: Brokerage view on Infosys, Dalmia Bharat, Havells and ONGCCiti has maintained a neutral rating on Infosys but increased the target price significantly from Rs 1,550 to Rs 1,850. This suggests they ...
19 Jul, 2024, 09.00 AM IST
Hot Stocks: Brokerage view on Emami, Godrej Consumer, Affle, Tech Mahindra, and othersCiti maintains a sell rating on Persistent (TP: Rs 3,080). Q1 shows strong growth but expects sequential margin decline, with Q2 at risk du...
09 Jul, 2024, 09.35 AM IST
Hot stocks: Brokerage take on L&T Finance, Bajaj Finance, Gujarat Gas, Sun Pharma, and othersBrokerage firms such as UBS have maintained a buy rating on L&T Finance, while JP Morgan maintained an overweight rating on Bajaj Finance, ...
04 Jul, 2024, 09.02 AM IST
Hot stocks: Brokerage view on HDFC Bank, M&M Finance and Avenue SupermartsJefferies and UBS rate HDFC Bank as Buy. Jefferies also buys M&M Finance; Citi is neutral on M&M. UBS reiterates Buy on HDFC Bank. Citi rat...
03 Jul, 2024, 09.04 AM IST
Hot Stocks: Brokerage view on Nuvama Wealth,Man Industries, Automotive ER&D, SRF and Bandhan BankInCred has a reduce rating for ER&D stocks Tata Tech and Tata Elxsi. Yes Securities suggests buying in Tech Mahindra, Indus Towers and Gran...
28 Jun, 2024, 08.58 AM IST
Hot Stocks: Brokerages view on Indian Hotels, Honasa Consumer, NMDC and PaytmCiti also maintained a buy rating on NMDC and BofA Securities recommended a buy on Paytm.
20 Nov, 2023, 10.02 AM IST
Hot Stocks: Brokerage view on HUL, Havells India, and IndigoUBS maintained a neutral rating on HUL with a target price of Rs 2860. Heightened regional competition may impact the pace of volume recove...
12 Sep, 2023, 10.20 AM IST
Indian banks' dependence on AT1 bonds limited, some impact on pricing likely: AnalystsThe AT-1 bonds of India's Yes Bank were written down in March 2020 after the Reserve Bank of India initiated a restructuring of the lender ...
21 Mar, 2023, 10.55 AM IST
Analyst Calls: Asian Paints, ICICI Securities, Bajaj Finserv, Newgen SoftwareCiti has maintained sell rating on GlaxoSmithKline Pharmaceuticals and revised target price to Rs 1330 from Rs 1240.
24 Oct, 2019, 07.28 AM IST